About the journal
APOPTOSIS is a journal published by Springer Science+Business Media in United Kingdom. It is listed in MEDLINE according to the sources read. Declared publication charge: 4,390 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Springer Science+Business Media
- ISSN
- 1360-8185 · 1573-675X
- Country
- United Kingdom
- Access
- Not open access / not declared
- Declared publication charge
- 4,390 EUR
- Declared peer-review model
- peer_review
- Official website
- https://link.springer.com/journal/10495
Index listings
- MEDLINE · 2000-01-01
- Indexing
- MEDLINE
- APC
- 4,390 EUR
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
3337
Last recorded publication year
2026
h-index
149
i10-index
2507
From OpenAlex open data (CC0).
Editorial & policy6
- Observed digital preservation (Keepers registry)— snapshot 2026-09-21
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 97%
- ORCID iDs in current deposits
- 16%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9712129
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Cell death mechanisms and regulation
- Cell death mechanisms and regulation
- Autophagy in Disease and Therapy
- Autophagy in Disease and Therapy
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Mitochondrial Function and Pathology
- Mitochondrial Function and Pathology
Show all subjects (50)
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
- Phagocytosis and Immune Regulation
- Phagocytosis and Immune Regulation
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Endoplasmic Reticulum Stress and Disease
- Endoplasmic Reticulum Stress and Disease
- NF-κB Signaling Pathways
- NF-κB Signaling Pathways
- interferon and immune responses
- interferon and immune responses
- Ubiquitin and proteasome pathways
- Ubiquitin and proteasome pathways
- Inflammasome and immune disorders
- Inflammasome and immune disorders
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- RNA modifications and cancer
- RNA modifications and cancer
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Immune Response and Inflammation
- Immune Response and Inflammation
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Cancer Research and Treatments
- Cancer Research and Treatments
- DNA Repair Mechanisms
- DNA Repair Mechanisms
- ATP Synthase and ATPases Research
- ATP Synthase and ATPases Research
- Immune cells in cancer
- Circular RNAs in diseases
- Circular RNAs in diseases
- Immune cells in cancer
- Cardiac Ischemia and Reperfusion
- Cardiac Ischemia and Reperfusion
- Epigenetics and DNA Methylation
- Bioactive Compounds and Antitumor Agents
- Epigenetics and DNA Methylation
- Bioactive Compounds and Antitumor Agents
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ